TFRC and colorectal carcinoma: This molecular imaging agent holds considerable promisefor facilitating precise patient stratification for TfR1-targetedantibody-drug conjugates, monitoring therapeutic target engagement,and guiding the optimization of individualized treatment regimens.Collectively, 68Ga-NOTA-TR01 represents a valuable toolfor advancing more precise and personalized management strategiesin CRC.